Market Report / Blue-chips decline 1.8% on Tel
Ha'aretz, Israel - 23 Dec 2002
... law suit and will now enjoy a 180-day exclusivity period to market 15 and 30 mg doses
of a generic version of Akzo Nobel's blockbuster antidepressant, Remeron. ...

Market Report / Waiting for Klein
Ha'aretz, Israel - 23 Dec 2002
... law suit and will now enjoy a 180-day exclusivity period to market 15 and 30 mg doses
of a generic version of Akzo Nobel's blockbuster antidepressant, Remeron. ...

Shares decline, led by Teva
Globes Online, Israel - 22 Dec 2002
... Teva’s Nasdaq-listed shares fell almost 3% on Thursday and another 3% on Friday,
despite a favorable ruling from a US court on the antidepressant Remeron on ...

Teva set to slump 6% on arbitrage gap
Globes Online, Israel - 22 Dec 2002
... Teva’s Nasdaq-listed shares fell almost 3% on Thursday and another 3% on Friday,
despite a favorable ruling from a US court on the antidepressant Remeron on ...

Patent blow to Akzo Nobel
Financial Times (subscription), UK - 21 Dec 2002
... a US federal district court delivered a summary judgement in favour of two pharmaceutical
manufacturers seeking to market cheaper rival versions of Remeron, an ...

Court rules Mylan did not infringe on patent
Pittsburgh Business Times, PA - 20 Dec 2002
... for Remeron, which has sales of $490 million. Mylan and a partner, Teva Pharmaceuticals
USA Inc., want to make a generic equivalent of Remeron. ...

Amsterdam shares slightly higher in volatile early afternoon ...
AFX Press - 20 Dec 2002
... downgrade after Akzo Nobel yesterday lost a court case against drugmakers wanting
to produce a generic version of the Dutch company's anti-depressant Remeron. ...

Akzo Nobel ratings placed on review for possible downgrade - ...
AFX Press - 20 Dec 2002
... announcement that a US court ruling will allow pharmaceutical rivals to sell low-cost
generic versions of the group's flagship pharmaceutical product, Remeron ...

Daily Briefing
The News Journal, DE - 19 Dec 2002
... to its ambitions of growing pharmaceutical sales, after a US court ruling opened
the way for rivals to produce variants of anti- depressant drug Remeron. ...

Market Report / TASE sank on Gulf war drums
Ha'aretz, Israel - 19 Dec 2002
... Yesterday the drugmaker announced that the New Jersey court ruled it is not infringing
a patent on anti-depressant drug Remeron, made by Organon, a unit of ...

Cima expects no effect from Remeron patent decision
Twin Cities Business Journal, MN - 19 Dec 2002
Cima Labs Inc. said it expects a US District Court ruling will have
little or no impact on sales of its Remeron SolTab medication. ...

UPDATE: European Stocks Head Lower; DAX Closes Down 2.0%
Yahoo Headlines - 19 Dec 2002
... of growing pharmaceutical sales, after a US court ruling opened the way for rivals
to produce variants of its cash-cow, the antidepressant drug Remeron. ...

Amsterdam shares close off lows after early Wall St gains - ...
AFX Press - 19 Dec 2002
... 1.42 eur or 4.6 pct to 29.42 after losing a court case against drugmakers wanting
to produce a generic version of the Dutch company's anti-depressant Remeron. ...

Thu: Tel Aviv 25 down 5.3% for the week
Globes Online, Israel - 19 Dec 2002
... arbitrage gap thanks to yesterday’s decision by the US District Court for the District
of New Jersey that its generic version of anti-depressant Remeron did ...

Amsterdam shares lower midday ahead of Blix address to UN ...
AFX Press - 19 Dec 2002
... Akzo Nobel was another notable decliner, losing 1.39 to 29.45 after a ruling
from the US court in favour of generic producers in the Remeron patent ...

Euroshares back in the red in volatile midday trade, Blix update ...
AFX Press - 19 Dec 2002
... in favour of generic drug manufacturers Teva Pharmaceuticals and Mylan Pharmaceutical
in the patent infringement lawsuit concerning the Dutch group's Remeron ...

Iraq threat unnerves TASE
Globes Online, Israel - 19 Dec 2002
... after announcing Wednesday that a US court had judged in its favor, saying it had
not infringed Akzo Nobel’s patent on depression treatment drug Remeron. ...

US court rules Teva did not infringe Remeron patent
Globes Online, Israel - 19 Dec 2002
... TEVA) announced on Wednesday that a US court had judged in its favor, saying it
had not infringed Akzo Nobel’s patent on depression treatment drug Remeron. ...

Teva wins Remeron lawsuit, but Akzo Nobel weighs
Ha'aretz, Israel - 19 Dec 2002
... on Thursday it might appeal against a US court ruling in favor of two rivals regarding
their generic versions of Akzo's top-selling anti-depression drug Remeron ...

Shares may decline as US prepares for war
Globes Online, Israel - 18 Dec 2002
... after it announced on Wednesday that a US court had judged in its favor, saying it
had not infringed Akzo Nobel’s patent on depression treatment drug Remeron ...

Akzo Nobel may appeal Remeron ruling
Forbes - 18 Dec 2002
... Thursday it might appeal against a US court ruling in favour of two rivals regarding
their generic versions of Akzo's top-selling anti-depression drug Remeron. ...

Melt-In-Your-Mouth Meds: For When You Don't Have a Spoonful of ...
Washington Post, DC - 16 Dec 2002
... later this month; Immodium, for diarrhea; NuLev, for symptoms of irritable bowel
syndrome; a version of the migraine drug Zomig; the antidepressant Remeron ...

Antidepressants May Cause Premature Delivery
ABC News - 11 Dec 2002
... delivery. Researchers did not look at some of the newest antidepressants
on the market, including Wellbutrin, Effexor and Remeron.

Antidepressants May Cause Premature Delivery
HealthCentral.com - 10 Dec 2002
... delivery. Researchers did not look at some of the newest antidepressants
on the market, including Wellbutrin, Effexor and Remeron.

Drug companies hooked on profit
Melbourne Herald Sun, Australia - 08 Dec 2002
... $110.88 a year. Antidepressant Remeron and Avanza are exactly the
same but Remeron attracts a $21.51 premium. Maker Organon says ...